Ionis Pharmaceuticals, Inc. logo

IONS

Ionis Pharmaceuticals, Inc.

$38.86

Earnings Summary

Revenue
$225.25Mn
Net Profits
$-66.27Mn
Net Profit Margins
-29.42%

Highlights

Revenue:

Ionis Pharmaceuticals, Inc.’s revenue jumped 19.81% since last year same period to $225.25Mn in the Q2 2024. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 88.5% jump in its revenue since last 3-months.

Net Profits:

Ionis Pharmaceuticals, Inc.’s net profit jumped 22.04% since last year same period to $-66.27Mn in the Q2 2024. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 53.6% jump in its net profits since last 3-months.

Net Profit Margins:

Ionis Pharmaceuticals, Inc.’s net profit margin jumped 34.93% since last year same period to -29.42% in the Q2 2024. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 75.38% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Ionis Pharmaceuticals, Inc. post its latest quarter earnings

EPS Estimate Current Year
-1.01

Highlights

EPS Estimate Current Year:

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -1.01.

Key Ratios

Key ratios of the Ionis Pharmaceuticals, Inc. post its Q2 2024 earnings

Earning Per Share (EPS)
-0.45
Return on Assets (ROA)
-0.08
Return on Equity (ROE)
-1.06

Highlights

Earning Per Share (EPS):

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) jumped 25% since last year same period to -0.45 in the Q2 2024. This indicates that the Ionis Pharmaceuticals, Inc. has generated 25% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Ionis Pharmaceuticals, Inc.’s return on assets (ROA) stands at -0.08.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Ionis Pharmaceuticals, Inc.’s return on equity (ROE) stands at -1.06.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-03-31
-1.05
-0.98
6.67%
2024-08-01
-0.92
-0.45
51.09%